Immunovant
Yan Zheng is the Vice President of Biostatistics and Programming at Immunovant. Yan has more than 15 years of drug development experience in industry holding various roles with Sarepta Therapeutics, Merck, Allergan, and Sanofi.
Prior to joining Immunovant Ms. Zheng served as the Head of Biometrics at Kaleido Biosciences, where she built and led the Biometrics team as well as the strategic and operational planning of biometrics resources and contributions. Yan possesses broad knowledge in diverse aspects of drug development including global program development planning, multi-regional clinical trial designing, conducting and analyzing across several therapeutical areas.
Yan earned a B.S. in Probability and Statistics from Peking University in China, and a M.S. and Ph.D. in Biostatistics from the University of Minnesota – Twin Cities, Minnesota.
This person is not in the org chart
This person is not in any offices
Immunovant
6 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.